Isavuconazole drug monitoring study for children with fungal infections
Part of Infections clinical trials.
This study monitors how the antifungal drug isavuconazole works in children's bodies. It aims to find the right dose for treating serious fungal infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 0 and 18 years old.
- Child has a serious fungal infection (invasive mycosis).
- Child is scheduled to take or is taking the antifungal drug isavuconazole.
- Guardian (and child if old enough) agrees to participate and signs a consent form.
- No known allergy to azole antifungal drugs (like fluconazole, voriconazole, etc.).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called isavuconazole, which is used to treat serious fungal infections. It aims to see if it is safe and works well in very sick patients in the intensive care unit (ICU).
This trial tests whether using a genetic test to set the first dose of voriconazole (an antifungal medicine) can make treatment safer and more effective for people with blood cancers. It aims to reduce side effects and improve how well the drug works.
This study looks for specific lab “biomarkers” in people with mucormycosis, a serious fungal infection. It compares results with people who have higher infection risk but no active infection, to help doctors diagnose and track this illness more accurately.
This study looks at how caspofungin works in children who are very sick and in the pediatric intensive care unit. It helps doctors better choose dosing to keep the medicine at the right level.
This study looks at how to best personalize the dose of the antifungal drug isavuconazole for older adults (60+) with serious fungal infections. By measuring drug levels in the blood, doctors hope to make treatment safer and more effective.
This study looks at how immune system problems relate to fungal infections, using medical records and lab tests on blood and tissue. It may help researchers understand the cause of these infections—especially for people with inherited immune conditions—and improve future care.
Hear when a new Aspergillosis Invasive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.